Nature of the Event

This is a corrigendum to a previously submitted Postal Ballot Notice dated 13th July 2026. It serves to correct an error in a shareholder's post-issue stake percentage and to formally propose enhanced lock-in requirements for a group of shareholders.

Key Quantitative Figures & Corrections

  • The post-issue shareholding percentage of Mr. B. K. Anilkumar was incorrectly stated as 4.81% in the original notice.
  • The corrected post-issue shareholding percentage is 4.45%.
  • The calculation for the correction is provided: (2,312,002 ÷ 51,893,711) × 100 = 4.45%.
  • The total post-preferential issue equity share capital of the company is 51,893,711 shares.
  • Mr. B. K. Anilkumar is confirmed to be a non-promoter shareholder and an Additional Director.

Parties Involved

  • Issuer: Arvaya Healthcare Limited (formerly Bijoy Hans Limited)
  • Regulators Addressed: BSE Limited
  • Shareholders Subject to Lock-in: 14 non-promoter individuals, all described as eminent medical professionals. The list includes J K Pradeepkumar (1,328,124 shares), B K Anilkumar (591,129 shares), and 12 others with allotments ranging from 12,663 to 63,273 shares.
  • Acquisition Target: Sushodha Institute of Gastroenterology Private Limited (SIGPL)
  • Company Officials: Kaushal Uttam Shah (Managing Director, DIN: 02175130) and Guinea Agrawal (Company Secretary & Compliance Officer)
  • Scrutinizer: Contact provided at chinmaylele2804@gamil.com for vote modifications.

Proposed Lock-in Structure

The company proposes a tiered lock-in structure for the 14 non-promoter shareholders, which is in addition to the minimum lock-in requirements prescribed under SEBI ICDR Regulations, 2018.

For the equity shares allotted to them, the lock-in will be:

  • 40% of the allotted shares: Locked-in for a period of three (3) years from the date of allotment.
  • 40% of the allotted shares: Locked-in for a period of two (2) years from the date of allotment.
  • 20% of the allotted shares: Locked-in for a period of one (1) year from the date of allotment.

Purpose & Rationale

The enhanced lock-in period is proposed because the allottees are "distinguished medical professionals with significant experience and accomplishments in the healthcare sector." The company seeks to foster a long-term strategic association with them, align their interests with the company's stakeholders, and ensure their continued engagement to support the company's business operations, growth strategy, and healthcare initiatives following the acquisition of SIGPL.

Voting Instructions

Members who had already cast their votes via e-Voting prior to receiving this corrigendum are permitted to modify their votes. To do so, they must write an email to the scrutinizer at chinmaylele2804@gamil.com on or before Thursday, August 13, 2026.

Governance

The Board of Directors recommends the Special Resolution for approval. It is confirmed that none of the Directors, Key Managerial Personnel, or their relatives are concerned or interested in this resolution, except to the extent of their shareholding in the company.

Document Availability

The corrigendum and the revised notice have been uploaded on the company's website (https://www.arvayahealth.com), the website of NSDL (www.evotingnsdl.com), and the website of BSE Limited (www.bseindia.com).